Perceptive Advisors LLC Nanobiotix S.A. Transaction History
Perceptive Advisors LLC
- $2.39 Billion
- Q1 2025
A detailed history of Perceptive Advisors LLC transactions in Nanobiotix S.A. stock. As of the latest transaction made, Perceptive Advisors LLC holds 105,053 shares of NBTX stock, worth $527,366. This represents 0.02% of its overall portfolio holdings.
Number of Shares
105,053
Previous 266,093
60.52%
Holding current value
$527,366
Previous $763,000
50.72%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding NBTX
# of Institutions
13Shares Held
6MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$28.2 Million6.69% of portfolio
-
Black Rock Inc. New York, NY239KShares$1.2 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY11.4KShares$57,1620.0% of portfolio
-
Geode Capital Management, LLC Boston, MA10.2KShares$51,1230.0% of portfolio
-
Morgan Stanley New York, NY6.1KShares$30,6210.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $175M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...